Month: September 2024

BROSSARD, Quebec, Sept. 26, 2024 (GLOBE NEWSWIRE) — DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a pioneer in early detection of critical health issues through the use of Artificial Intelligence (AI) technologies, announces the voting results of its annual general and special meeting of shareholders held on September 25, 2024. Election of directors The following directors were elected to hold office until the closing of the next annual meeting of the shareholders; Mr. André Larente, Mr. Francis Bellido, Mr. Robert Dunn, Mr. Michael Braeuel and Mr. Philippe Couillard. Appointment of auditor Raymond Chabot Grant Thornton LLP was re-appointed as auditor of the Corporation for the ensuing year. Amendment to the stock option plan The shareholders of the Corporation approved a special resolution...

Publication date of the results and the Annual Financial Report fiscal period ended 31 January 2024 SURESNES, France – (26 September 2024) — PROACTIS (ISIN code : FR0004052561) announces that, the publication of its results and Annual Financial Report for the year ended January 31, 2024, originally scheduled for May 31, 2024, will take place on September 26, 2024. PROACTIS SA’s Annual General Meeting of Shareholders will be held on October 17, 2024, at 1:30 pm. PROACTIS SA had obtained authorization from the President of the Nanterre Commercial Court to postpone this meeting until October 31, 2024. * * * * About Proactis SA (https://www.proactis.com/proactis-sa), a Proactis Company Proactis SA connects companies by providing business spend management and collaborative business process automation solutions for both goods and services,...

ABC arbitrage announces that as of today its financial report for the first half of 2024 has been publicly released and filed with the Autorité des Marchés Financiers (AMF). This document includes the following parts:The half-year activity report The consolidated financial statements as of June 30, 2024 The statutory auditors’ report Statement by the person responsible for the financial reportThe annual financial report can be consulted on the Group website at: abc-arbitrage.com, in the “Shareholders” page, heading Financial information / Financial reports.Contacts : abc-arbitrage.comRelations actionnaires : actionnaires@abc-arbitrage.comRelations presse: VERBATEE / v.sabineu@verbatee.com EURONEXT Paris – Compartiment BISIN : FR0004040608Reuters  BITI.PA / Bloomberg ABCA FPAttachment2024 ABCA...

Titan’s respective annual general and special meeting of shareholders to vote on the amalgamation transaction to take place on September 30, 2024, at 4:00 p.m. Eastern Time TORONTO, Ontario, Sept. 26, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Conavi Medical Inc. (“Conavi”) has received the requisite shareholder approval required to proceed with the proposed combination of Titan and Conavi (the “Amalgamation”) in an all-stock transaction (the “Transaction”). This Transaction will constitute a reverse takeover of Titan. The Conavi shareholder approval of the Amalgamation was obtained at a special meeting of its shareholders (the “Conavi Special Meeting”) held today, September 26, 2024. 100% of the shares voted at the Conavi Special Meeting, were voted in favor of the proposal...

Check Point is acknowledged for its ability to execute and completeness of vision REDWOOD CITY, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (NASDAQ: CHKP), a leading cyber security platform provider of AI-powered, cloud delivered solutions, today announced that it has been recognized as a Visionary in the 2024 Gartner® Magic Quadrant™ for Endpoint Protection Platforms. Check Point Harmony Endpoint is shaping the future of workspace security with flexible deployment options and a unified security approach, offering robust endpoint protection tailored to organizations of any scale. Businesses today are grappling with more advanced cyber threats aimed particularly at endpoints, highlighted by Check Point Research’s report of a 30% increase in global cyber-attacks in the second quarter...

First award under UNICEF emergency tender to secure availability of mpox vaccines for AfricaCOPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN® mpox vaccine for countries in Africa impacted by the mpox outbreak. Under the agreement, UNICEF will procure 1 million doses of the vaccine which includes the 500,000 doses that were committed by Gavi and announced on September 18, 2024. As part of Bavarian Nordics commitment to increase and prioritize its production capacity to fulfil the short- and medium-term demand, the Company will make all doses available for supply before the end of 2024 and will work with UNICEF and its partners to swiftly deliver the vaccines upon request. Paul Chaplin, President & CEO of Bavarian Nordic,...

COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024. Based on today’s announced mpox vaccine order and additional orders secured, combined with improved performance in Travel Health, as well as other parts of the business, Bavarian Nordic now expects revenue between DKK 5,400 million and DKK 5,800 million and EBITDA between DKK 1,450 million and DKK 1,700 million. Revenue from the Travel Health business is now expected at approximately DKK 2,200 million, the Public Preparedness business between DKK 3,000 million and DKK 3,400 million and Other Revenue unchanged at approximately DKK 200 million. The Public Preparedness guidance is based on secured orders, as well as several smaller orders expected to be signed soon. The revenue interval represents uncertainty related to logistics...